Form 4: P&G Director Joseph Jimenez Granted Restricted Stock Units
Insider Transaction Report
Procter & Gamble Director Joseph Jimenez received a grant of 341 Restricted Stock Units, increasing his beneficial ownership to 36,083.677 shares.
Summary
- Joseph Jimenez, a Director of Procter & Gamble Co (PG), acquired 341 shares of common stock in the form of Restricted Stock Units (RSUs).
- The transaction occurred on December 9, 2025, with a transaction price of $0 per share, indicating a grant rather than a purchase.
- These RSUs were awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
- The total beneficial ownership of Joseph Jimenez following this transaction is 36,083.677 shares.
- The total includes the grant of dividend equivalents also in the form of Restricted Stock Units.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 6
Explanation: Slightly positive as it indicates continued alignment of a director's interests with shareholders through equity compensation, which is a standard and healthy corporate governance practice.
Positives
- The grant of Restricted Stock Units to Director Joseph Jimenez aligns his interests with those of shareholders, as his compensation is tied to the company's future performance.
- The transaction is part of a pre-arranged 10b5-1 plan, indicating a structured approach to insider transactions.
Negatives
- No direct negatives are apparent from this standard compensation filing.
Risks
- No specific risks are mentioned in this Form 4 filing.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This RSU grant is a common form of executive and director compensation in large, publicly traded companies like Procter & Gamble, designed to incentivize long-term performance and align insider interests with shareholder value. Such grants are standard practice across various industries for retaining and motivating key personnel.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of director compensation is a widely adopted practice among S&P 500 companies, including peers in the consumer staples sector such as Unilever, Kimberly-Clark, and Colgate-Palmolive.
- The grant price of $0 for RSUs is standard, as these represent future equity awards that vest over time, rather than open market purchases.
- The disclosure of the transaction under a Rule 10b5-1 plan is also a common corporate governance practice, demonstrating a pre-planned approach to insider trading to avoid accusations of trading on material non-public information.
Stakeholder Impact
- Shareholders: Positive impact due to increased alignment of a director's financial interests with the company's long-term performance.
Next Steps
- The filing does not mention any specific future actions, events, or milestones.
Key Dates
| Date | Description |
|---|---|
| 12/09/2025 | Date of transaction (acquisition of Restricted Stock Units) |
| 12/10/2025 | Date Form 4 was filed |
Keywords
Procter & Gamble, PG, Joseph Jimenez, Restricted Stock Units, RSU, Insider Transaction, Form 4, Director Compensation, Equity Grant, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.